Y200-1093 Screening compound: N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]cyclopropanecarboxamide

Y200-1093 Screening compound: N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]cyclopropanecarboxamide
Y200-1093 Screening compound: N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]cyclopropanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-1093
N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]cyclopropanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-1093

Molecular Formula

C13H11FN2OS (C13 H11 FN2 OS)

Compound Name

N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]cyclopropanecarboxamide

IUPAC name

N-[4-(4-fluorophenyl)-13-thiazol-2-yl]cyclopropanecarboxamide

SMILES

O=C(C1CC1)Nc1nc(-c(cc2)ccc2F)cs1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

262.31

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

3.929

Distribution Coefficient, logD

3.929

Water Solubility, LogSw

-4.19

Polar Surface Area

33.628

Acid Dissociation Constant (pKa)

11.75

Base Dissociation Constant (pKb)

-0.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

Y200-1093 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y200-1093 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-1093?
Check Price and Availability of Y200-1093, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-1093 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-1093
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-1093
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-1093 available by request